Marked improvement in the resolution of, and survival rates in, spontaneous bacterial peritonitis.
Suzuki
Kazuyuki
K
Takikawa
Yasuhiro
Y
D002443:Ceftriaxone / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007958:Leukocyte Count; D008103:Liver Cirrhosis / Q000150:complications*; D009504:Neutrophils; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D011379:Prognosis; D012307:Risk Factors; D015996:Survival Rate
D002511:Cephalosporins; D002443:Ceftriaxone